Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study
AuthorBalteskard Rinde, Ludvig; Lind, Caroline; Småbrekke, Birgit; Njølstad, Inger; Mathiesen, Ellisiv B.; Wilsgaard, Tom; Løchen, Maja-Lisa; Mathiesen Hald, Erin; Vik, Anders; Brækkan, Sigrid Kufaas; Hansen, John-Bjarne; Rinde, Ludvig Balteskard
Objectives: We aimed to study the association between incident myocardial infarction (MI) and VTE in a prospective population-based cohort.
Methods: Study participants (n=29 506) were recruited from three surveys of the Tromsø Study (conducted in 1994-95, 2001-02 and 2007-08) and followed through 2010. All incident events of MI and VTE during follow-up were recorded. Cox-regression models with age as time scale and MI as a time-dependent variable were used to calculate hazard ratios (HR) of VTE adjusted for sex, BMI, blood pressure, diabetes mellitus, HDL-cholesterol, smoking, physical activity and education level.
Results: During a median follow-up of 15.7 years, 1 853 participants experienced a MI and 699 experienced a VTE. MI was associated with a 51% increased risk of VTE (HR 1.51; 95% CI 1.08-2.10) and a 72% increased risk of pulmonary embolism (PE) (HR 1.72; 95% CI 1.07-2.75), but not significantly associated with risk of deep vein thrombosis (DVT) (HR 1.36, 95% CI, 0.86-2.15). The highest risk estimates for PE were observed during the first sixth months after the MI (HR 8.49; 95% CI 4.00-18.77). MI explained 6.2% of the PEs in the population (population attributable risk) and 78.5% of the PE risk in MI-patients (attributable risk).
Conclusions: Our findings indicate that MI is associated with a transient increased risk of VTE independent of traditional atherosclerotic risk factors. The risk estimates were particularly high for PE.
CitationRinde LB, Lind C, Småbrekke B, Njølstad I, Mathiesen EB, Wilsgaard T, Løchen M-L, Hald EM, Vik A, Brækkan SK, Hansen J-B. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost 2016; 14: 1183–91.
Showing items related by title, author, creator and subject.
Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma : VEGF-A Impact Is Strongly Associated with Ang-2 Andersen, Sigve; Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VEGF-A. 335 unselected stage I-IIIA NSCLC-patients were included and tissue samples of respective tumor cells and ...
Humant papillomavirus : en litteraturstudie om HPV, dets relasjon til cancer og tiltak mot videre spredning av virus Gabrielsen, Endre (Master thesis; Mastergradsoppgave, 2012-06-01)I 1983 oppdaget zur Hausen sammenhengen mellom Humant Papillomavirus (HPV) og livmorhalskreft. På denne tiden visste man ikke at det var HPV som var årsaken til at Helaceller kunne leve in vitro. Ny forskning relaterer HPV til en rekke andre cancertyper. En stor andel anal-, oropharyngeal-, penis-, vaginal-, og vulvacancer skyldes HPV. Det er også påvist HPV i tumorvev fra øsofagus, larynx, lunge, ...
Hoem, Gry (Master thesis; Mastergradsoppgave, 2012-06)Fragile X syndrome (FXS) is caused by an expanded CGG repeat (>200 repeats) in the 5’ un-translated portion of the fragile mental retardation 1 gene (FMR1) leading to deficiency or absence of the FMR1 protein (FMRP). FMRP is an RNA carrier protein that controls the translation of a number of other genes that regulate synaptic development and plasticity. Autism occurs in approximately 30% of FXS ...